Ontology highlight
ABSTRACT: Background
Transfusion-dependent thalassaemia (TDT) is a hereditary blood disorder in which blood transfusion is the mainstay treatment to prolong survival and improve quality of life. Patients with this disease require blood transfusion at more than 100 ml/kg annually and iron-chelating therapy (ICT) to prevent iron overload (IOL) complications. There are substantial numbers of TDT patients in Malaysia, but limited data are available regarding the economic burden associated with this disease. The purpose of this study was to determine the lifetime cost of TDT from a societal perspective and identify potential factors increasing patient and family expenditures among thalassaemia populations.Methods
The total lifetime cost per TDT patient (TC1) is the sum of lifetime healthc
SUBMITTER: Shafie AA
PROVIDER: S-EPMC8028190 | biostudies-literature | 2021 Apr
REPOSITORIES: biostudies-literature